Cialis results

Short- and long-term follow-up results of daily 5-mg tadalafil as a treatment for erectile dysfunction and premature ejaculation.
Objective: To evaluate the safety and effectiveness of daily 5-mg tadalafil treatment for men who have erectile dysfunction (ED) and premature ejaculation (PE), and to assess the long-term follow-up for ED and PE improvement persistence years after the cessation of medication.
Patients and methods: A prospective, single-blind, randomised study included 160 patients with ED and PE. All were evaluated using the International Index of Erectile Function (IIEF-5) questionnaire to evaluate ED and intravaginal ejaculatory latency time (IELT) for PE. Patients were subdivided into two equal groups. Group I (80 patients) treated with daily 5-mg tadalafil for 3 months, and Group II (80 patients) treated with a placebo for the same period. After 3 months of treatment and 2 years later after cessation of tadalafil, all patients were assessed for ED and PE.
Results: The mean (SD) IELT and IIEF-5 score pre-treatment were 37 (11.24) s and 13.2 (4.2) for Group I, while in Group II they were 35.98 (10.8) s and 13.12 (4.11), respectively. After 3 months of treatment, the mean (SD) IELT in Group I showed a highly significant improvement from 37 (11.24) s to 120.5 (47.37) s ( P P > 0.05]. For the IIEF-5 score, there was a highly significant improvement from baseline to 20.45 (4.5) in Group I ( P P > 0.05]. At 2 years after cessation of tadalafil, there was statistically significant improvement in the IELT and IIEF-5 from baseline to endpoint .
Conclusion: Oral daily 5-mg tadalafil was effective, tolerable, and safe treatment for patients with ED and PE. Long-term follow-up at 2 years confirmed the persistence of a significant improvement for both ED and PE. Abbreviations : ED: erectile dysfunction; IIEF-5: five-item version of the International Index of Erectile Function questionnaire; IELT: intravaginal ejaculatory latency time; OAD: once-daily; PDE5i: phosphodiesterase-5 inhibitors; PE: premature ejaculation; PRN: pro re nata .
Keywords: Tadalafil; erectile dysfunction; premature ejaculation.
© 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
Conflict of interest statement.
No potential conflict of interest was reported by the author(s).
Similar articles.
Abou Faddan AH, Gaber HD, Oamonov D. Abou Faddan AH, et al. Arab J Urol. 2022 Feb 26;20(2):100-104. doi: 10.1080/2090598X.2021.2007464. eCollection 2022. Arab J Urol. 2022. PMID: 35530567 Free PMC article.
Onal B, Can O, Ermec B, Culha MG. Onal B, et al. Eur Rev Med Pharmacol Sci. 2023 May;27(9):4248-4253. doi: 10.26355/eurrev_202305_32335. Eur Rev Med Pharmacol Sci. 2023. PMID: 37203851.
Karabakan M, Keskin E, Akdemir S, Bozkurt A. Karabakan M, et al. Int Braz J Urol. 2017 Mar-Apr;43(2):317-324. doi: 10.1590/S1677-5538.IBJU.2016.0376. Int Braz J Urol. 2017. PMID: 27819758 Free PMC article.
Corona G, Rastrelli G, Limoncin E, Sforza A, Jannini EA, Maggi M. Corona G, et al. J Sex Med. 2015 Dec;12(12):2291-300. doi: 10.1111/jsm.13041. Epub 2015 Nov 9. J Sex Med. 2015. PMID: 26552599 Review.
Prasetyo DT, Raharja PAR, Mantiri BJ, Ringoringo DRL, Rahman IA, Felizio J, Tambunan MP, Fadhly SF, Rahardjo HE. Prasetyo DT, et al. Acta Med Indones. 2019 Jul;51(3):275-281. Acta Med Indones. 2019. PMID: 31699953 Review.
References.
Porst H, Montorsi F, Rosen RC, et al. The premature ejaculation prevalence and attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seeking. Eur Urol. 2007;51(3):816–824. – PubMed Hatzimouratidis K, Amar E, Eardley I, et al. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol. 2010;57(5):804–814. – PubMed Althof SE, McMahon CG, Waldinger MD, et al. An update of the international society of sexual medicine’s guidelines for the diagnosis and treatment of premature ejaculation (PE). J Sex Med. 2014;11(6):1392–1422. – PubMed Lotti F, Corona G, Mancini M, et al. The association between varicocele, premature ejaculation and prostatitis symptoms: possible mechanisms. J Sex Med. 2009;6(10):2878–2887. – PubMed Canat L, Erbin A, Canat M, et al. Assessment of hormonal activity in patients with premature ejaculation. Int Braz J Urol. 2017;43(2):311–316. – PMC – PubMed.
Related information.
Grant support.
The authors received no financial support for the research, authorship, or publication of this article.
LinkOut – more resources.
Full Text Sources.